Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02869880 · ClinicalTrials.gov registry record · NA
Trial of Enhanced Pre-Consent Discussion
A NA study of Pediatric Crohn's Disease, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 241
- Enrollment target
- 1
- Study location
NCT02869880: Completed NA study of Pediatric Crohn's Disease, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT02869880 is a NA study of Pediatric Crohn's Disease that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 241 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02869880, a NA study of Pediatric Crohn's Disease, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 241 participants
- Enrollment target
- 1
- Study location
Study Summary
Nested within the COMBINE pragmatic clinical trial, the investigators will conduct a cluster randomized controlled trial to determine whether, in parents (of children with Crohn's Disease) or patients \> 18 years old being approached for trial participation, a pre-consent discussion enhanced with decision aids is more effective than the standard pre-consent discussion in transferring knowledge to parents/patients related to trial participation.
Primary Outcome
Number correct on 5-item Knowledge Related to Trial Participation survey
Conditions Studied
Interventions
- OTHER Enhanced Pre-Consent Discussion
- OTHER Standard Pre-consent Discussion
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 241 participants |
| Start Date | 2016-10 |
| Est. Completion | 2019-07 |
| Phase | NA |
What the finished NCT02869880 record still lists
NCT02869880 is an interventional study that assigns participants to a tested intervention. The registered 241 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 1 condition, with Pediatric Crohn's Disease appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Pre-Consent Discussion is the first listed.
NCT02869880 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02869880 about?
NCT02869880 is a clinical study titled "Trial of Enhanced Pre-Consent Discussion". Nested within the COMBINE pragmatic clinical trial, the investigators will conduct a cluster randomized controlled trial to determine whether, in parents (of children with Crohn's Disease) or patients \> 18 years old being approached for trial participation, a pre-consent discussion enhanced with de...
What is the current status of trial NCT02869880?
This trial is currently completed. It is a NA study. The enrollment target is 241 participants. The study started on 2016-10. Estimated completion is 2019-07.
What conditions does trial NCT02869880 study?
This clinical trial studies the following conditions: Pediatric Crohn's Disease.
What interventions are being tested in trial NCT02869880?
The interventions under investigation include: Enhanced Pre-Consent Discussion (OTHER), Standard Pre-consent Discussion (OTHER).
Who is sponsoring clinical trial NCT02869880?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02869880 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Crohn's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02869880's enrollment target sits among peer trials
241 440th of 2000 higher than 1,561 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01189786 · 241 participants · NA
Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
- NCT05050383 · 241 participants · NA
DISE: Phenotyping Obstruction Patterns
- NCT05683418 · 241 participants · Phase 1
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors
- NCT07213791 · 241 participants · Phase 1
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia